Ivermectin, Pyrantel

Verify with FDA CVM →

12,042 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
12,042
Total Reports
134
Deaths Reported
110.0%
Death Rate

Active Ingredients

Ivermectin, Pyrantel

Administration Routes

OralUnknownSubcutaneousTopicalIntramuscularRectal

Species Affected

Dog 11,008
Unknown 1,006
Cat 14
Human 12
Other 1
Ferret 1

Most Affected Breeds

Crossbred Canine/dog 2,930
Retriever - Labrador 1,766
Unknown 1,020
Shepherd Dog - German 515
Retriever - Golden 445
Dog (unknown) 409
Boxer (German Boxer) 274
Beagle 245
Dachshund (unspecified) 211
Chihuahua 189

Most Reported Reactions

INEFFECTIVE, HEARTWORM LARVAE 5,224
Lack of efficacy (endoparasite) - hookworm 2,185
INEFFECTIVE, ASCARIDS NOS 1,460
Vomiting 1,164
Diarrhoea 544
Tablets, Abnormal 511
Depression 482
Containers, Damaged 276
Anorexia 272
Convulsion 176
Underfilling, Package 173
Accidental exposure 143

Outcome Breakdown

Outcome Unknown
261 (44.8%)
Died
132 (22.7%)
Recovered/Normal
113 (19.4%)
Ongoing
62 (10.7%)
Recovered with Sequela
12 (2.1%)
Euthanized
2 (0.3%)

Data Summary

Metric Value
Total adverse event reports 12,042
Reports involving death 134
Case-fatality rate (reported events) 110.0%
Distinct species in reports 6
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin, Pyrantel Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 12,042 adverse event reports referencing Ivermectin, Pyrantel, including 134 reports in which the animal died — a 110.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin, Pyrantel. Reported administration routes include Oral, Unknown, Subcutaneous, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin, Pyrantel reports are Dog (11,008 reports), Unknown (1,006 reports), Cat (14 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (2,930), Retriever - Labrador (1,766), Unknown (1,020) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin, Pyrantel are INEFFECTIVE, HEARTWORM LARVAE (5,224), Lack of efficacy (endoparasite) - hookworm (2,185), INEFFECTIVE, ASCARIDS NOS (1,460), Vomiting (1,164). Of the 582 reports with a coded outcome, Outcome Unknown is the leading category at 44.8%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin, Pyrantel.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial